Tonicity is the capability of a solution to modify the volume of cells by altering their water content. The movement of water into a cell can lead to hypotonicity or hypertonicity when water moves out of the cell. The movement of water then causes the cell to swell or shrink in size through osmotic pressure differences between the intracellular compartment (IC) and the solution tested. Solutions are isotonic when the volume of cells suspended in them does not change by osmotic fluid transfers.
Osmosis refers to the net movement of water, across a selectively permeable membrane, towards the location of higher osmotic concentration.
Osmolarity is the term used for describing the concentration of solutes within a fluid. The terms isotonic, hypertonic, and hypotonic compare the osmolarity of a cell to the osmolarity of the extracellular fluid around it. Hyperosmolarity doesn't always mean hypertonicity because this depends on the solutes. Solutes such as Na+ and glucose, for example, need transporters, they contribute to serum tonicity and are termed effective osmoles (contributing to osmolarity). Meanwhile, urea and ethanol easily pass through cell membranes, contributing to serum osmolality but not tonicity.
Disturbances in tonicity are the major clinical disorders affecting volume, proper function, and survival of cells. It causes water movement into or out of cells, thereby diluting or concentrating intracellular ions. Numerous mechanisms use the movement of water for cells to maintain their homeostatic size and functioning. Hyperosmolality itself alters several intracellular processes, including cell volume regulation, cell cycle, intracellular ion homeostasis, macromolecular and nucleic acid stability, and can induce apoptosis.
When typical mechanisms of homeostasis are unable to regulate tonicity, cell damage can occur secondary to prolonged hypertonicity and from fast onset hypertonicity. Clinically, hyperglycemic and hypernatremic states are the main etiologies for disease-causing hypertonicity. Cell shrinking secondary to hypertonicity can cause severe clinical manifestations and even death.
In a hypertonic environment, cells use membrane proteins called aquaporin channels to take advantage of the osmotic pressure gradient and shift water towards the higher concentration medium. Cells are permeable to water, and thanks to this, they can shrink and elevate the concentration of intracellular solutes. The survival mechanisms used by cells include the accumulation of organic osmolytes and increased expression of proteins through numerous pathways, resulting in osmotolerance. The shrinkage of cells generates stress that is commonly adjusted pathways involving Na+, K+-ATPase (in steady conditions). "Fast" volume regulation due to rapid activation of membrane ion transporters and "slow" adaptation to chronic changes in extracellular osmolarity involving modifications in gene expression and intracellular organic osmolyte content.
In steady-state conditions, a fundamental property of cells is that they contain a significant amount of large-molecular-weight anionic colloids, mostly proteins and organic phosphates, to which the plasma membrane is impermeable. The restriction of these proteins within a compartment that is impermeable to them allows for the Donnann effect. The Donnann effect describes the production of a higher concentration due to the inability of certain particles to cross a semi-permeable membrane, generating osmotic forces between the extracellular and intracellular compartment.
Hypertonicity denotes a relative excess of the solute with extracellular distribution over body water regardless of whether body water is normal, reduced, or excessive. The gain of extracellular solutes leads to the osmotic exit of water from the intracellular compartment to dilute the extracellular solutes. Sodium salts, which include sodium chloride and sodium bicarbonate, are the major extracellular solutes and routinely indicate hypertonicity when elevated.
Under hypertonic conditions, ions such as Na, Cl, and K accumulate in the cytosol and get exchanged for compatible organic osmolytes that do not perturb intracellular protein structure or function. A fast response is driven by the rapid activation of Na+,K+,2Cl- co-transporter, and the Na+/H+ exchanger, which couples to Cl-/H2CO3- anion exchanger.
On the other hand, TonEBP (tonicity-responsive enhancer-binding protein), which is also known as NFAT5 or OREBP, is a transcription factor that can promote the cellular accumulation of organic osmolytes in the hypertonic renal medulla. This is done by stimulating expression of its target genes in the kidneys, but it is also abundantly expressed in the brain, heart, liver, and activated T-cells.
Additionally, there is evidence that osmotic stress elicits a morphological disruption of the transverse tubular system in skeletal muscle fibers. The transverse tubular system is a continuation of the surface membrane that forms a junction with the sarcoplasmic reticulum and is known for its storage of calcium. It is the primary interface between the myoplasm and the extracellular environment, and these arrangements are essential to produce muscle contraction.
Regulation of osmolarity and volume play an essential role in maintaining body water balance and tonicity.
The acute adaptation to hypertonicity consists of ''regulatory volume increase'' (RVI). It requires the activation of the Na+,K+,2Cl- co-transporter, and the Na+/H+ exchanger, which couples to the Cl-/H2CO3- anion exchanger. These last two bring NaCl and KCl into the cell and moves H2CO3 out of it. The H2CO3 is then converted to CO2 and returns to the pool of H+ and HCO3- inside the cells. The thermodynamically obliged movement of water also follows the return of H2CO3. Sodium-ion entering the cells is extruded through Na/K ATPase in exchange for potassium, forming potassium chloride, which is the final salt gained intracellularly in hypertonicity.
Meanwhile, with chronic adaptation, the general response to hypertonicity is the activation of the transcription factor tonicity (TonEBP), leading to increased cellular expression of organic osmolyte transporters and enzymes. Some of the transcriptions of genes that TonEBP produces are aldose reductase (AR), betaine/GABA transporter(BGT1), sodium myoinositol transporter (SMIT), and taurine transporter (TauT). The transcription of Hsp70, urea transporters (UTA1 and -2), and water channel aquaporin-2 (AQP2) increase cell membrane water permeability and is also activated by TonEBP.
Cells that are shrunken by hypertonicity responds initially with RVI. It increases the uptake of inorganic salts and the osmotic influx of water, but this results in high intracellular inorganic salt concentration that can perturb cellular function and structure. In order to counteract this, cells activate TonEBP for the transcription of genes for aldose reductase (for the synthesis of sorbitol) and transporters of betaine, inositol, and taurine. This process accumulates large amounts of organic osmolytes, which provide an osmoprotective effect.
Most cells in mammals are generally not stressed by hypertonicity because of the close control of the concentration of NaCl in virtually all extracellular body fluids. The renal inner medulla is a striking exception. This is because of its urinary concentrating mechanism where it has routine exposure to extremely high concentrations of sodium chloride (NaCl) and urea. The adaptation of medullary cells to hyperosmotic stress involves acute cellular efflux of water, cell shrinkage by NaCl, chronic accumulation of compatible organic osmolytes, and acute activation of immediate-early and heat shock genes. Renal medullary cells do not restrict this mechanism, which also happens to cells in other tissues when exposed to pathologic conditions that produce hypertonic states.
The predominant clinical syndromes of hypertonicity are hypernatremia and hyperglycemia. Rises in tonicity from changes in body water, body solute, or both can be assessed testing osmolarity in serum and urine and correlating it with the level of electrolytes in these two compartments to establish the cause of the impairment. The serum osmolarity normal range is 280 to 295mOsm/ kgH2O and normal urine osmolality is from 50mOsm/kgH2O to 1400mOsm/kgH2O. Normal serum sodium is 135 to 145mmol/L, and the urinary sodium reference range varies with the diet.
Tonicity is under tightly regulation by the equilibrium between water intake and water excretion. Normal conditions where water loss occurs is with respiration, within gastrointestinal fluids, in urine, and through the skin. The problem occurs when patients are unable to replete those losses. When the osmoreceptors in the hypothalamus sense the increase in serum tonicity, water intake is suggested by the stimulation of thirst. In addition, the kidney's primary reaction to water loss is through concentrating the urine. Just 1% of the change in tonicity is enough to produce ADH release, but it needs a greater than 10% fall in extracellular volume to be released. ADH acts on the V2 receptors in the principal cells of the collecting tubules within kidneys and causes the expression of aquaporins for water movement from the tubules to the hypertonic interstitium.
One of the cardinal manifestations of a hyperglycemic crisis is hypertonicity. The excess of glucose in the extracellular fluid has a hypertonic effect and produces an osmotic diuresis that can cause water loss to exceed the losses of sodium and potassium. This results in an elevated sodium concentration within the cell and will stimulate thirst.
High-glucose conditions in patients with diabetic microvascular complications, particularly with diabetic nephropathy, have shown TonEBP to upregulate the expression of AR. The production of AR in cells that can produce the enzyme is desired for the enzyme's ability to catalyze the reaction of glucose to sorbitol. The inability of sorbitol to cross cell membranes and its accumulation within the cell aides in counteracting the osmotic stress placed on cells during a hyperglycemic event. AR is present in tissues such as nerve, retina, lens, glomerulus, and within vascular cells.
During acute states of tonicity variability, the brain is also in danger. The primary defensive adaptation occurs through RVI, but astrocytes also play a major role by accepting the movement of water from the cerebrospinal fluid.
Acute hypertonicity most often affects children and the elderly more than other ages. Patients commonly develop fever, nausea, and vomiting. In children, symptoms can range from irritability, restlessness, muscular twitching to hyperreflexia, and seizures. In the elderly, seizures rarely present, but patients can present with lethargy, delirium, and end up in a coma. On the other hand, chronic hypertonicity may manifest with only subtle neurological changes because it has more time to adapt to the medium, even when hypertonicity is severe.
Conditions causing hypernatremia due to inadequate water intake are associated with:
It can also result from excessive water loss, such as in:
Glucose is an osmotically active substance that causes the movement of water out of the cells and, subsequently, a reduction of serum sodium levels by dilution. Therefore it is crucial to correct serum sodium for hyperglycemia, which is calculated by adding to measured [Na] 1.6 mmol/L for every 100 mg/dL (5.55 mmol/L) increment of serum glucose above normal. Under other conditions, uncontrolled hyperglycemic patients produce osmotic diuresis losing water and then causing a hypovolemic state presenting with signs such as orthostatic hypotension, increased pulse rate, decreased skin turgor, flat neck veins, and dry mucous membranes. The osmotic diuresis during uncontrolled hyperglycemia can ultimately lead to hypernatremia if there is not sufficient replacement of this water loss. For that reason, in patients
with diabetes mellitus, sodium concentration can be variable on presentation. This is due to the hyperglycemia-induced water movement out of the cells that lower Na and the glucosuria induced osmotic diuresis.
|||Argyropoulos C,Rondon-Berrios H,Raj DS,Malhotra D,Agaba EI,Rohrscheib M,Khitan Z,Murata GH,Shapiro JI,Tzamaloukas AH, Hypertonicity: Pathophysiologic Concept and Experimental Studies. Cureus. 2016 May 2; [PubMed PMID: 27382523]|
|||Agrawal V,Agarwal M,Joshi SR,Ghosh AK, Hyponatremia and hypernatremia: disorders of water balance. The Journal of the Association of Physicians of India. 2008 Dec; [PubMed PMID: 19322975]|
|||Lado MG,Sheu SS,Fozzard HA, Effects of tonicity on tension and intracellular sodium and calcium activities in sheep heart. Circulation research. 1984 May; [PubMed PMID: 6723001]|
|||Bortner CD,Cidlowski JA, Absence of volume regulatory mechanisms contributes to the rapid activation of apoptosis in thymocytes. The American journal of physiology. 1996 Sep; [PubMed PMID: 8843726]|
|||Betten R,Scharner B,Probst S,Edemir B,Wolff NA,Langelueddecke C,Lee WK,Thévenod F, Tonicity inversely modulates lipocalin-2 (Lcn2/24p3/NGAL) receptor (SLC22A17) and Lcn2 expression via Wnt/β-catenin signaling in renal inner medullary collecting duct cells: implications for cell fate and bacterial infection. Cell communication and signaling : CCS. 2018 Nov 7; [PubMed PMID: 30404645]|
|||Mongin AA,Orlov SN, Mechanisms of cell volume regulation and possible nature of the cell volume sensor. Pathophysiology : the official journal of the International Society for Pathophysiology. 2001 Dec; [PubMed PMID: 11720802]|
|||Hoffmann EK,Lambert IH,Pedersen SF, Physiology of cell volume regulation in vertebrates. Physiological reviews. 2009 Jan; [PubMed PMID: 19126758]|
|||Bolton GR,Boesch AW,Basha J,Lacasse DP,Kelley BD,Acharya H, Effect of protein and solution properties on the Donnan effect during the ultrafiltration of proteins. Biotechnology progress. 2011 Jan-Feb; [PubMed PMID: 21312362]|
|||Rondon-Berrios H,Argyropoulos C,Ing TS,Raj DS,Malhotra D,Agaba EI,Rohrscheib M,Khitan ZJ,Murata GH,Shapiro JI,Tzamaloukas AH, Hypertonicity: Clinical entities, manifestations and treatment. World journal of nephrology. 2017 Jan 6; [PubMed PMID: 28101446]|
|||Neuhofer W,Beck FX, Cell survival in the hostile environment of the renal medulla. Annual review of physiology. 2005; [PubMed PMID: 15709969]|
|||Lee SD,Choi SY,Lim SW,Lamitina ST,Ho SN,Go WY,Kwon HM, TonEBP stimulates multiple cellular pathways for adaptation to hypertonic stress: organic osmolyte-dependent and -independent pathways. American journal of physiology. Renal physiology. 2011 Mar; [PubMed PMID: 21209002]|
|||Woo SK,Lee SD,Kwon HM, TonEBP transcriptional activator in the cellular response to increased osmolality. Pflugers Archiv : European journal of physiology. 2002 Aug; [PubMed PMID: 12194010]|
|||Hernández-Ochoa EO,Robison P,Contreras M,Shen T,Zhao Z,Schneider MF, Elevated extracellular glucose and uncontrolled type 1 diabetes enhance NFAT5 signaling and disrupt the transverse tubular network in mouse skeletal muscle. Experimental biology and medicine (Maywood, N.J.). 2012 Sep; [PubMed PMID: 22966145]|
|||Schulze Blasum B,Schröter R,Neugebauer U,Hofschröer V,Pavenstädt H,Ciarimboli G,Schlatter E,Edemir B, The kidney-specific expression of genes can be modulated by the extracellular osmolality. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2016 Oct; [PubMed PMID: 27464968]|
|||Burg MB,Kwon ED,Kültz D, Regulation of gene expression by hypertonicity. Annual review of physiology. 1997; [PubMed PMID: 9074772]|
|||Umenishi F,Yoshihara S,Narikiyo T,Schrier RW, Modulation of hypertonicity-induced aquaporin-1 by sodium chloride, urea, betaine, and heat shock in murine renal medullary cells. Journal of the American Society of Nephrology : JASN. 2005 Mar; [PubMed PMID: 15647343]|
|||Hu B,Han Q,Mengke N,He K,Zhang Y,Nie Z,Zeng H, Prognostic value of ICU-acquired hypernatremia in patients with neurological dysfunction. Medicine. 2016 Aug; [PubMed PMID: 27583842]|
|||Kitabchi AE,Umpierrez GE,Miles JM,Fisher JN, Hyperglycemic crises in adult patients with diabetes. Diabetes care. 2009 Jul; [PubMed PMID: 19564476]|
|||Kim SJ,Kim H,Park J,Chung I,Kwon HM,Choi WS,Yoo JM, Tonicity response element binding protein associated with neuronal cell death in the experimental diabetic retinopathy. International journal of ophthalmology. 2014; [PubMed PMID: 25540742]|
|||Giacco F,Brownlee M, Oxidative stress and diabetic complications. Circulation research. 2010 Oct 29; [PubMed PMID: 21030723]|
|||Liamis G,Liberopoulos E,Barkas F,Elisaf M, Diabetes mellitus and electrolyte disorders. World journal of clinical cases. 2014 Oct 16; [PubMed PMID: 25325058]|